Jorjani Biomedicine Journal

1. World health organization [Internet].Geneva: World Health Organization; 2021 [cited 2026 Feb 8]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. [View at Publisher]

2. Piché M-E, Tchernof A, Després J-P. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res. 2020;126(11):1477-500. [View at Publisher] [DOI] [PMID] [Google Scholar]

3. Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217. [View at Publisher] [DOI] [PMID] [Google Scholar]

4. Lowe DA, Wu N, Rohdin-Bibby L, Moore AH, Kelly N, Liu YE, et al. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Intern Med. 2020;180(11):1491-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

5. World Obesity Federation .Org [Internet]. One billion people globally estimated to be living with obesity by 2030. London: World Obesity Federation; 2022 [cited 2026 Feb 8]. Available from: https://www.worldobesity.org/news/one-billion-people-globally-estimated-to-be-living-with-obesity-by-2030. [View at Publisher]

6. Hu L, Huang X, You C, Li J, Hong K, Li P, et al. Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China. PLoS One. 2017;12(9):e0183934. [View at Publisher] [DOI] [PMID] [Google Scholar]

7. Jiang S-Z, Lu W, Zong X-F, Ruan H-Y, Liu Y. Obesity and hypertension. Exp Ther Med. 2016;12(4):2395-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

8. Ibal AM, Jamal SF. Essential hypertension. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. [View at Publisher] [PMID] [Google Scholar]

9. Cohen JB, Gadde KM. Weight Loss Medications in the Treatment of Obesity and Hypertension. Curr Hypertens Rep. 2019;21(2):16. [View at Publisher] [DOI] [PMID] [Google Scholar]

10. do Carmo JM, da Silva AA, Wang Z, Fang T, Aberdein N, de Lara Rodriguez CE, et al. Obesity-Induced Hypertension: Brain Signaling Pathways. Curr Hypertens Rep. 2016;18(7):58. [View at Publisher] [DOI] [PMID] [Google Scholar]

11. El Meouchy P, Wahoud M, Allam S, Chedid R, Karam W, Karam S. Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control. Int J Mol Sci. 2022;23(20):12305. [View at Publisher] [DOI] [PMID] [Google Scholar]

12. Xi Y, Gao W, Zheng K, Lv J, Yu C, Wang S, et al. The Roles of Genetic and Early-Life Environmental Factors in the Association Between Overweight or Obesity and Hypertension: A Population-Based Twin Study. Front Endocrinol (Lausanne). 2021;12:743962. [View at Publisher] [DOI] [PMID] [Google Scholar]

13. Kumar J. Epidemiology of hypertension. Clinical Queries: Nephrology. 2013;2(2):56-61. [View at Publisher] [DOI] [Google Scholar]

14. Akpa OM, Made F, Ojo A, Ovbiagele B, Adu D, Motala AA, et al. Regional Patterns and Association Between Obesity and Hypertension in Africa: Evidence From the H3Africa CHAIR Study. Hypertension. 2020;75(5):1167-78. [View at Publisher] [DOI] [PMID] [Google Scholar]

15. Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020;9(1):80-93. [View at Publisher] [DOI] [PMID] [Google Scholar]

16. Shihab HM, Meoni LA, Chu AY, Wang NY, Ford DE, Liang KY, et al. Body mass index and risk of incident hypertension over the life course: the Johns Hopkins Precursors Study. Circulation. 2012;126(25):2983-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

17. Mouton AJ, Li X, Hall ME, Hall JE. Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation. Circ Res. 2020;126(6):789-806. [View at Publisher] [DOI] [PMID] [Google Scholar]

18. Lu Q, Zhang Y, Geng T, Yang K, Guo K, Min X, et al. Association of Lifestyle Factors and Antihypertensive Medication Use With Risk of All-Cause and Cause-Specific Mortality Among Adults With Hypertension in China. JAMA Netw Open. 2022;5(2):e2146118. [View at Publisher] [DOI] [PMID] [Google Scholar]

19. Ozemek C, Tiwari S, Sabbahi A, Carbone S, Lavie CJ. Impact of therapeutic lifestyle changes in resistant hypertension. Prog Cardiovasc Dis. 2020;63(1):4-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

20. Di Palo KE, Barone NJ. Hypertension and Heart Failure: Prevention, Targets, and Treatment. Heart Fail Clin. 2020;16(1):99-106. [View at Publisher] [DOI] [PMID] [Google Scholar]

21. Hinderliter AL, Smith P, Sherwood A, Blumenthal J. Lifestyle Interventions Reduce the Need for Guideline-Directed Antihypertensive Medication. Am J Hypertens. 2021;34(10):1100-7. [View at Publisher] [DOI] [PMID] [Google Scholar]

22. Guo R, Li N, Yang R, Liao X-Y, Zhang Y, Zhu B-F, et al. Effects of the Modified DASH Diet on Adults With Elevated Blood Pressure or Hypertension: A Systematic Review and Meta-Analysis. Front Nutr. 2021;8:725020. [View at Publisher] [DOI] [PMID] [Google Scholar]

23. Song Y, Lobene AJ, Wang Y, Hill Gallant KM. The DASH Diet and Cardiometabolic Health and Chronic Kidney Disease: A Narrative Review of the Evidence in East Asian Countries. Nutrients. 2021;13(3):984. [View at Publisher] [DOI] [PMID] [Google Scholar]

24. Wickman BE, Enkhmaa B, Ridberg R, Romero E, Cadeiras M, Meyers F, et al. Dietary Management of Heart Failure: DASH Diet and Precision Nutrition Perspectives. Nutrients. 2021;13(12):4424. [View at Publisher] [DOI] [PMID] [Google Scholar]

25. Filippou CD, Tsioufis CP, Thomopoulos CG, Mihas CC, Dimitriadis KS, Sotiropoulou LI, et al. Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2020;11(5):1150-60. [View at Publisher] [DOI] [PMID] [Google Scholar]

26. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982-1004. [View at Publisher] [DOI] [PMID] [Google Scholar]

27. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. [View at Publisher] [DOI] [PMID] [Google Scholar]

28. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. [View at Publisher] [DOI] [PMID] [Google Scholar]

29. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ . 2011;343:d5928. [View at Publisher] [DOI] [PMID] [Google Scholar]

30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. [View at Publisher] [DOI] [PMID] [Google Scholar]

31. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. [View at Publisher] [DOI] [PMID] [Google Scholar]

32. Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785-805. [View at Publisher] [DOI] [PMID] [Google Scholar]

33. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Stat Med. 2002;21(11):1539-58. [View at Publisher] [DOI] [PMID] [Google Scholar]

34. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6. [View at Publisher] [DOI] [PMID] [Google Scholar]

35. Al-Solaiman Y, Jesri A, Mountford WK, Lackland DT, Zhao Y, Egan BM. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010;24(4):237-46. [View at Publisher] [DOI] [PMID] [Google Scholar]

36. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes care. 2005;28(12):2823-31. [View at Publisher] [DOI] [PMID] [Google Scholar]

37. Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin P-H, et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med. 2010;170(2):126-35. [View at Publisher] [DOI] [PMID] [Google Scholar]

38. Burke V, Beilin LJ, Cutt HE, Mansour J, Wilson A, Mori TA. Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial. J Hypertens. 2005;23(6):1241-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

39. Chen ST, Maruthur NM, Appel LJ. The effect of dietary patterns on estimated coronary heart disease risk: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Circ Cardiovasc Qual Outcomes. 2010;3(5):484-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

40. Choi S-H, Choi-Kwon S. The effects of the DASH diet education program with omega-3 fatty acid supplementation on metabolic syndrome parameters in elderly women with abdominal obesity. Nutr Res Pract. 2015;9(2):150-7. [View at Publisher] [DOI] [PMID] [Google Scholar]

41. Conlin PR, Erlinger TP, Bohannon A, Miller ER, Appel LJ, Svetkey LP, et al. The DASH diet enhances the blood pressure response to losartan in hypertensive patients. Am J Hypertens. 2003;16(5):337-42. [View at Publisher] [DOI] [PMID] [Google Scholar]

42. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006;144(7):485-95. [View at Publisher] [DOI] [PMID] [Google Scholar]

43. Hinderliter AL, Sherwood A, Craighead LW, Lin P-H, Watkins L, Babyak MA, et al. The long-term effects of lifestyle change on blood pressure: One-year follow-up of the ENCORE study. Am J Hypertens. 2014;27(5):734-41. [View at Publisher] [DOI] [PMID] [Google Scholar]

44. Juraschek SP, Miller ER, Weaver CM, Appel LJ. Effects of sodium reduction and the DASH diet in relation to baseline blood pressure. Journal of the American College of Cardiology. J Am Coll Cardiol. 2017;70(23):2841-8. [View at Publisher] [DOI] [PMID] [Google Scholar]

45. Kucharska A, Gajewska D, Kiedrowski M, Sińska B, Juszczyk G, Czerw A, et al. The impact of individualised nutritional therapy according to DASH diet on blood pressure, body mass, and selected biochemical parameters in overweight/obese patients with primary arterial hypertension: a prospective randomised study. Kardiol Pol. 2018;76(1):158-65. [View at Publisher] [DOI] [PMID] [Google Scholar]

46. Lima STRM, de Souza BdSN, França AKT, Salgado Filho N, Sichieri R. Dietary approach to hypertension based on low glycaemic index and principles of DASH (Dietary Approaches to Stop Hypertension): a randomised trial in a primary care service. Br J Nutr. 2013;110(8):1472-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

47. Lin P-H, Allen JD, Li Y-J, Yu M, Lien LF, Svetkey LP. Blood pressure-lowering mechanisms of the DASH dietary pattern. J Nutr Metab. 2012;2012:472396. [View at Publisher] [DOI] [PMID] [Google Scholar]

48. Malloy-McFall J, Barkley JE, Gordon KL, Burzminski N, Glickman EL. Effect of the DASH diet on pre-and stage 1 hypertensive individuals in a free-living environment. Nutr Metab Insights. 2010:3:15-23. [View at Publisher] [DOI] [PMID] [Google Scholar]

49. Moore TJ, Conlin PR, Ard J, Svetkey LP. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension. 2001;38(2):155-8. [View at Publisher] [DOI] [PMID] [Google Scholar]

50. Nowson CA, Wattanapenpaiboon N, Pachett A. Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women. Nutr Res. 2009;29(1):8-18. [View at Publisher] [DOI] [PMID] [Google Scholar]

51. Prather AA, Blumenthal JA, Hinderliter AL, Sherwood A. Ethnic differences in the effects of the DASH diet on nocturnal blood pressure dipping in individuals with high blood pressure. Am J Hypertens. 2011;24(12):1338-44. [View at Publisher] [DOI] [PMID] [Google Scholar]

52. Said MS, El Sayed IT, Ibrahim EE, Khafagy GM. Effect of DASH diet versus healthy dietary advice on the estimated atherosclerotic cardiovascular disease risk. J Prim Care Community Health. 2021;12:2150132720980952. [View at Publisher] [DOI] [PMID] [Google Scholar]

53. Smith PJ, Blumenthal JA, Babyak MA, Craighead L, Welsh-Bohmer KA, Browndyke JN, et al. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension. 2010;55(6):1331-8. [View at Publisher] [DOI] [PMID] [Google Scholar]

54. Sorić T, Mavar M, Rumbak I. The effects of the dietary approaches to stop hypertension (DASH) diet on metabolic syndrome in hospitalized schizophrenic patients: A randomized controlled trial. Nutrients. 2019;11(12):2950. [View at Publisher] [DOI] [PMID] [Google Scholar]

55. Paula Bricarello L, Poltronieri F, Fernandes R, Retondario A, de Moraes Trindade EBS, de Vasconcelos FAG. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on blood pressure, overweight and obesity in adolescents: A systematic review. Clin Nutr ESPEN. 2018;28:1-11. [View at Publisher] [DOI] [PMID] [Google Scholar]

56. Theodoridis X, Triantafyllou A, Chrysoula L, Mermigkas F, Chroni V, Dipla K, et al. Impact of the Level of Adherence to the DASH Diet on Blood Pressure: A Systematic Review and Meta-Analysis. Metabolites. 2023;13(8):924. [View at Publisher] [DOI] [PMID] [Google Scholar]

57. Campbell NRC, Ordunez P, Giraldo G, Rodriguez Morales YA, Lombardi C, Khan T, et al. WHO HEARTS: A Global Program to Reduce Cardiovascular Disease Burden: Experience Implementing in the Americas and Opportunities in Canada. Can J Cardiol. 2021;37(5):744-55. [View at Publisher] [DOI] [PMID] [Google Scholar]

58. Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RA, Acharya S, et al. Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary. Hypertension. 2022;79(1):293-301. [View at Publisher] [DOI] [PMID] [Google Scholar]

59. Smith DK, Lennon RP, Carlsgaard PB. Managing Hypertension Using Combination Therapy. Am Fam Physician. 2020;101(6):341-9. [View at Publisher] [PMID] [Google Scholar]

60. Filippou C, Tatakis F, Polyzos D, Manta E, Thomopoulos C, Nihoyannopoulos P, et al. Overview of salt restriction in the Dietary Approaches to Stop Hypertension (DASH) and the Mediterranean diet for blood pressure reduction. Rev Cardiovasc Med. 2022;23(1):36. [View at Publisher] [DOI] [PMID] [Google Scholar]

61. Akhlaghi M. Dietary Approaches to Stop Hypertension (DASH): potential mechanisms of action against risk factors of the metabolic syndrome. Nutr Res Rev. 2020;33(1):1-18. [View at Publisher] [DOI] [PMID] [Google Scholar]

62. Zhang Z, Zhou X, Mei Y, Bu X, Tang J, Gong T, et al. Novel low-sodium salt formulations combined with Chinese modified DASH diet for reducing blood pressure in patients with hypertension and type 2 diabetes: a clinical trial. Front Nutr. 2023;10:1219381. [View at Publisher] [DOI] [PMID] [Google Scholar]

63. Chen J, Sanderson MJ. Store-operated calcium entry is required for sustained contraction and Ca(2+) oscillations of airway smooth muscle. J Physiol. 2017;595(10):3203-18. [View at Publisher] [DOI] [PMID] [Google Scholar]

64. Chan Q, Wren GM, Lau CE, Ebbels TMD, Gibson R, Loo RL, et al. Blood pressure interactions with the DASH dietary pattern, sodium, and potassium: The International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP). Am J Clin Nutr. 2022;116(1):216-29. [View at Publisher] [DOI] [PMID] [Google Scholar]

65. Nomura N, Shoda W, Uchida S. Clinical importance of potassium intake and molecular mechanism of potassium regulation. Clin Exp Nephrol. 2019;23(10):1175-80. [View at Publisher] [DOI] [PMID] [Google Scholar]

66. Su X-T, Yang C-L, Ellison DH. Kidney Is Essential for Blood Pressure Modulation by Dietary Potassium. Curr Cardiol Rep. 2020;22(10):124. [View at Publisher] [DOI] [PMID] [Google Scholar]

67. Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension. 2010;56(3):453-62. [View at Publisher] [DOI] [PMID] [Google Scholar]

68. Cunha AR, Umbelino B, Correia ML, Neves MF. Magnesium and Vascular Changes in Hypertension. Int J Hypertens. 2012;2012:754250. [View at Publisher] [DOI] [PMID] [Google Scholar]

69. DiNicolantonio JJ , Liu J, O'Keefe JH. Magnesium for the prevention and treatment of cardiovascular disease. Open Heart. 2018;5(2):e000775. [View at Publisher] [DOI] [PMID] [Google Scholar]

70. Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant. 2013;28(4):869-78. [View at Publisher] [DOI] [PMID] [Google Scholar]

71. Kircelli F, Peter ME, Sevinc Ok E, Celenk FG, Yilmaz M, Steppan S, et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant. 2012;27(2):514-21. [View at Publisher] [DOI] [PMID] [Google Scholar]

72. Gorgels TG, Waarsing JH, de Wolf A, ten Brink JB, Loves WJ, Bergen AA. Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticum. J Mol Med (Berl). 2010;88(5):467-75. [View at Publisher] [DOI] [PMID] [Google Scholar]

73. Bai Y, Zhang J, Xu J, Cui L, Zhang H, Zhang S, et al. Magnesium prevents β-glycerophosphate-induced calcification in rat aortic vascular smooth muscle cells. Biomed Rep. 2015;3(4):593-7. [View at Publisher] [DOI] [PMID] [Google Scholar]

74. Ter Braake AD, Smit AE, Bos C, van Herwaarden AE, Alkema W, van Essen HW, et al. Magnesium prevents vascular calcification in Klotho deficiency. Kidney Int. 2020;97(3):487-501. [View at Publisher] [DOI] [PMID] [Google Scholar]

75. Diaz-Tocados JM, Peralta-Ramirez A, Rodríguez-Ortiz ME, Raya AI, Lopez I, Pineda C, et al. Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats. Kidney Int. 2017;92(5):1084-99. [View at Publisher] [DOI] [PMID] [Google Scholar]

76. Garcia-Perez I, Posma JM, Gibson R, Chambers ES, Hansen TH, Vestergaard H, et al. Objective assessment of dietary patterns by use of metabolic phenotyping: a randomised, controlled, crossover trial. Lancet Diabetes Endocrinol. 2017;5(3):184-95. [View at Publisher] [DOI] [PMID] [Google Scholar]

77. Loo RL, Zou X, Appel LJ, Nicholson JK, Holmes E. Characterization of metabolic responses to healthy diets and association with blood pressure: application to the Optimal Macronutrient Intake Trial for Heart Health (OmniHeart), a randomized controlled study. Am J Clin Nutr. 2018;107(3):323-34. [View at Publisher] [DOI] [PMID] [Google Scholar]

78. Soltani S, Arablou T, Jayedi A, Salehi-Abargouei A. Adherence to the dietary approaches to stop hypertension (DASH) diet in relation to all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Nutr J. 2020;19(1):37. [View at Publisher] [DOI] [PMID] [Google Scholar]

79. Balasubramaniam J, Hewlings SJ. A Systematic Review of the Efficacy of DASH Diet in Lowering Blood Pressure Among Hypertensive Adults. Top Clin Nutr. 2021;36(2):158-76. [View at Publisher] [DOI] [Google Scholar]

80. Wang NX, Arcand J, Campbell NRC, Johnson C, Malta D, Petersen K, et al. The World Hypertension League Science of Salt: a regularly updated systematic review of salt and health outcomes studies (Sept 2019 to Dec 2020). J Hum Hypertens. 2022;36(12):1048-58. [View at Publisher] [DOI] [PMID] [Google Scholar]

81. Newberry SJ, Chung M, Anderson CAM, Chen C, Fu Z, Tang A, et al . Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks Comparative Effectiveness Review No. 206. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018. [View at Publisher] [DOI] [PMID] [Google Scholar]

82. Smyth A, O'Donnell MJ, Yusuf S, Clase CM, Teo KK, Canavan M, et al. Sodium Intake and Renal Outcomes: A Systematic Review. Am J Hypertens. 2014;27(10):1277-84. [View at Publisher] [DOI] [PMID] [Google Scholar]

83. Vargas-Meza J, Gonzalez-Rocha A, Campos-Nonato I, Nilson EAF, Basto-Abreu A, Barquera S, et al. Effective and Scalable Interventions to Reduce Sodium Intake: a Systematic Review and Meta-Analysis. Curr Nutr Rep. 2023;12(3):486-94. [View at Publisher] [DOI] [PMID] [Google Scholar]

84. Aljuraiban GS, Jose AP, Gupta P, Shridhar K, Prabhakaran D. Sodium intake, health implications, and the role of population-level strategies. Nutr Rev. 2021;79(3):351-9. [View at Publisher] [DOI] [PMID] [Google Scholar]

85. Patel Y, Joseph J. Sodium Intake and Heart Failure. Int J Mol Sci. 2020;21(24):9474. [View at Publisher] [DOI] [PMID] [Google Scholar]

86. Van Regenmortel N, Moers L, Langer T, Roelant E, De Weerdt T, Caironi P, et al. Fluid-induced harm in the hospital: look beyond volume and start considering sodium. From physiology towards recommendations for daily practice in hospitalized adults. Ann Intensive Care. 2021;11(1):79. [View at Publisher] [DOI] [PMID] [Google Scholar]

87. Choi D-H, Cho J-Y, Koo J-H, Kim T-K. Effects of Electrolyte Supplements on Body Water Homeostasis and Exercise Performance during Exhaustive Exercise. Appl. Sci. 2021;11(19):9093. [View at Publisher] [DOI] [Google Scholar]

88. Klingert M, Nikolaidis PT, Weiss K, Thuany M, Chlíbková D, Knechtle B. Exercise-Associated Hyponatremia in Marathon Runners. J Clin Med. 2022;11(22):6775. [View at Publisher] [DOI] [PMID] [Google Scholar]

89. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. The Cochrane database of systematic reviews. 2004(3):Cd004937. [View at Publisher] [DOI]

90. Choi JW, Park J-S, Lee CH. Interactive effect of high sodium intake with increased serum triglycerides on hypertension. PLOS ONE. 2020;15(4):e0231707. [View at Publisher] [DOI] [PMID] [Google Scholar]

91. Huang L, Trieu K, Yoshimura S, Neal B, Woodward M, Campbell NRC, et al. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. BMJ. 2020;368:m315. [View at Publisher] [DOI] [PMID] [Google Scholar]